Generic Semaglutide: Lower-Cost Semaglutide is Here!
BUY NOW
We Ship To The U.S. Only
Generic Semaglutide: Lower-Cost Semaglutide is Here!
We Ship To The U.S. Only
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
Diabetes management medication has become very popular for the obvious reason and the not-so-obvious one. Two medications have made taking charge of a patient’s diabetes (and weight) easier, Ozempic and Mounjaro. As their popularity grows, and the market for each changes, many patients have considered switching from one to the other. If one plans on doing this it is important to understand that a certain dosage in one doesn’t directly carry over to the other. Keep reading to learn how to switch between Ozempic and Mounjaro safely.
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
No official conversion ratio has been approved yet for those who want to switch between Ozempic and Mounjaro. However, there are some guidelines that can be used to help those who choose to do this. Mounjaro stays within the body for about 25 days and Ozempic can stay in the body for about 5 weeks. Most patients will be instructed to wait at least a week after their last dose before switching medications.
Mounjaro is a more potent medication. Patients making this conversion will need to consider this potency. They will also need to monitor their tolerance of their starting dose and assess their risk of developing side effects. Doctors will likely look at the patients’ Ozempic dose and how well it was tolerated. Mounjaro may then be prescribed to be started in small doses to test further tolerability before increasing doses.
Ozempic and Mounjaro function similarly and are both weekly injections; they differ in what dosage amounts they offer. Ozempic comes in 0.25 mg, 0.5 mg, 1 mg, and 2 mg pens. Mounjaro comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg dosages. The charts below compare not only the medications themselves but the dosage conversion between them.
| Ozempic | Mounjaro | Notes |
|---|---|---|
| 0.25 mg | 2.5 mg |
|
| 0.5 mg | 2.5 mg |
|
| 1 mg | 5 mg |
|
| 2 mg | 5 mg – 7.5 mg |
|
| – | 7.5 mg |
|
| – | 10 mg |
|
| – | 12.5 mg |
|
| – | 15 mg |
|
| Ozempic | Mounjaro | |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Blood Sugar Reduction Results | 1.83% | Less than 2.30% |
| Body Weight Reduction Results | 10% | 20% |
| Administration | Weekly shot | Weekly shot |
| Starter Dosage | 0.25 – 0.5 mg | 2.5 mg |
| Common Maintenance Dose | 1 mg | 5 mg |
| Side Effects | Nausea, vomiting, diarrhea | Nausea, vomiting, and diarrhea are more common with Mounjaro |
| How It Works |
|
|
| Available Doses | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
|
Ozempic uses the active ingredient semaglutide. It is a GLP-1 receptor agonist which helps enhance insulin secretion. Along with type 2 diabetes management, Ozempic has also become famous for its weight loss capabilities. Injections of this medication are usually taken once every week.
Ozempic is designed to work in a similar way to bariatric surgery in that it slows down digestive processes in the body and causes the food to take a longer time to pass through. This causes patients to feel full more quickly and consume less food. This leads to weight loss over time in most cases. This medication also helps with blood sugar level regulation by causing patients’ pancreases to make more insulin. It also lowers the secretion of glucose.
Mounjaro contains Tirzepatide—a medication that acts as both a GLP-1 receptor agonist and a GIP receptor agonist.This two-front approach enhances insulin secretion and helps people drop weight even better than Ozempic in many cases. Injections of this medication are also usually taken once every week and it is approved for use in type 2 diabetes treatment.
This medication can help manage blood sugar levels like Ozempic. It can also help with weight loss. However, there are some differences. One of the main differences is that Mounjaro is usually prescribed to patients in higher doses. Mounjaro also works by mimicking two different hormones in the body—not just one—making it often produce better weight-loss related results. It helps with weight loss in a similar way to Ozempic. It also helps slow down gastric emptying and makes patients feel fuller for longer periods of time—thus reducing food intake.
Improved Glycemic Control
Keeping one’s blood sugar in a healthy range as much as possible is the number one goal of diabetics when it comes to their medication. While both medications lower patients’ hemoglobin A1C levels, Mounjaro seems to perform better than Ozempic.
Patient-Specific Responses to Medications
Unfortunately, popularity does not make a medication one-size-fits-all. Patients may see little to no results on Ozempic, or their bodies might react negatively. Switching medications can mean massive improvements in treatment or side effects.
Cost and Insurance
Both are comparable in price, settling themselves in the $1,400 per month range. However, insurance policies sometimes cover only one of these medications. Availability in one’s area can also affect price.
Better Weight Loss Results
Studies show that Mounjaro is often more effective for weight loss. Those taking Ozempic can lose up to 15% or 20% of their body weight on the medication. However, there are many patients who only lose closer to 10% on the medication. Those taking Mounjaro often lose over 20% of their body weight.
Plateaus on Ozempic
Some people make the switch from Ozempic to Mounjaro if they are experiencing a plateau in weight loss while on the medication. Sometimes switching these medications can help results start to pick back up after the body has gotten too used to the original medication that was being taken and becomes less responsive to it.
Physician Preference and Insurance Coverage
Patients may also switch between these drugs if their doctor suggests Mounjaro may be a better fit for them or if they can get better insurance coverage on the medication. Different insurance plans may include different lists of medications they cover. Some patients may benefit more from Mounjaro—such as for off-label weight loss use—than they would with Ozempic.
Patient-Led Transitions Based on Anecdotal Results Patients may initiate a transition between medications themselves after reading through reports online and determining which medication may be better for helping them get the results they are trying for. For example, patients trying to lose weight more quickly may switch to Mounjaro after reading the studies of how that medication can lead to more weight loss.
There is no replacement for a doctor who knows patients and their bodies. They will be able to provide the best information on dosage conversion and answer any specific questions—such as questions about what to expect on the medication and their insurance coverage. They should also have a record on file of the patient’s medical history and be able to help them find a medication and dosing plan that would work best for them without causing serious side effects.
Doctors should be able to help patients come up with a more specific timeline for when to stop Ozempic and start Mounjaro. They should also be able to help them find their ideal dosing schedule during this transition.
Both medications tend to cause similar side effects. Keep an eye out if they get worse or if new ones pop up. These might be growing pains or something more serious. All new—and especially worsening—symptoms are important to keep track of. This will help patients get the medical attention they need and allow for doctors to make any necessary adjustments to their schedule in follow-up appointments. It may be helpful to keep track of all of these symptoms in a journal that can easily be referenced later.
A better diet and other lifestyle changes—like exercise and proper sleep—work hand in hand with the right medication. Patients taking these medications should try to eat smaller meal portions. They also include foods like vegetables and sources of protein in their diet. The medications also work best when accompanied by exercise plans. These tips can help patients get the best results out of their medication and prevent muscle loss as their weight begins to drop.
Mounjaro is usually prescribed to be taken in 2.5 mg increments that are increased every four weeks once patients switch from Ozempic. This slow progression helps patients avoid side effects—like nausea/diarrhea or appetite loss—and gives their body more time to adjust to the medication.
| Week 1-4 | 2.5 mg |
| Week 5-8 | 5 mg |
| Week 9-12 | 7.5 mg |
| Week 13+ | Up to 15 mg (if needed) |
Side effects of these medications often include those such as nausea or vomiting. Patients on Ozempic or Mounjaro also commonly experience a loss of appetite or other issues like diarrhea. Some ways to help reduce these symptoms include:
Patients should contact their doctor if any symptoms of the medication begin to become severe or do not resolve on their own.
Studies have generally shown that more A1C reduction and weight loss occur for patients who are taking a tirzepatide rather than a semaglutide. A study in 2023 found that each of three different tirzepatide doses was more effective for lowering A1C compared to respective doses of semaglutide. This medication was also more effective for reducing patients’ weight than semaglutide. Another study in 2023 found that those taking tirzepatide were eight times as likely to lose 5% of their weight and three times as likely to lose 15% of their weight compared to those taking Ozempic.
Appetite suppression for patients taking these medications may start occurring in as quickly as one to two weeks after the medication is started. Many patients taking these medications can also expect to lose about 10 lbs to 25+ lbs within the first few months of taking Mounjaro. Patients on these medications also commonly report positive side effects such as increases in energy levels and a reduction in food obsession.
The exact results the patient will experience from the medication depend on adherence and the progression of their dosage. It may also be impacted by their lifestyle—such as whether or not they are taking their medication with a diet and exercise plan. Some patients may encounter a plateau in weight loss after an initial period of success. Clinical trial data show that—even with continued treatment—the rate of weight reduction slows over time and most participants reach a plateau by around 72 weeks—or roughly 1.5 years. Higher doses and factors such as younger age and female sex may delay the time to plateau. Almost all patients experience plateaus after taking the medication for an extended period of time. Other patients may experience severe side effects such as persistent nausea, gastrointestinal discomfort, or fatigue. This can impact adherence and may require dose adjustments or a change in medication.
Yes. Switching back is possible in a few different scenarios. A doctor may suggest a patient switch back to Ozempic if they are not tolerating Mounjaro well. Switching back may help alleviate symptoms that developed during the initial switch.
Patients also may switch back if there have been changes to their insurance coverage or if they decide they prefer how Ozempic affects them over the effects of Mounjaro. Switching should never be done without recommendation and careful monitoring from a doctor. This reversal will also require another titration plan and patients will need to start low again.
While Ozempic and Mounjaro are very similar in what they treat and how they work, the differences between them can make it difficult to switch between the two.
Mounjaro performs better in clinical trials in both blood sugar and weight reduction. However, switching to this more potent medication which uses a two-fold approach has the possibility of dropping your blood sugar too much, causing another dangerous condition, hypoglycemia.
Given their different potencies and mechanisms, a dosage conversion chart is an important starting point when switching between Ozempic and Mounjaro. Patients should always consult with a doctor when deciding to switch between the two medications.
Switching medications may be just what you need to take control over your diabetes. Working with a doctor is one of the most important factors when switching between Mounjaro and Ozempic. They will provide a safe dosage conversion considering any unique factors and monitor the results.
Purchase affordable Ozempic and Mounjaro from Canada at Duty Free Meds.
Mounjaro and Ozempic use different formulas and active ingredients which results in different dosage options. Mounjaro has performed better than Ozempic in clinical trials, but not because it is necessarily stronger.
The highest dosage of Ozempic is equivalent to either the 5 mg or 7.5 mg dosage of Mounjaro.
Short answer, no. Long answer, these medications have two different active ingredients and (while similar) react differently in the body. Mixing these medications can accidentally cause a double dose or extreme side effects, causing more harm than good.
Switching from one medication to another can improve your diabetes. You might have some different side effects or results, but when monitored by a doctor switching medications can help if you aren’t seeing the results you want with another one.
This can vary greatly between patients and what dose you are starting at, you can see results within a few days or up to 5 weeks.
Many doctors may consider 5 mg of Mounjaro to be comparable in effect to 1 mg of Ozempic. However, they are different medications and are not 100% equivalent. Mounjaro is more potent and works on two different receptors. Different patients may have different responses to the medication.
Patients are typically advised to wait at least 7 days after their last Ozempic dose before starting Mounjaro. However, the exact timing depends on the patient’s health status and the doctor’s instructions.
No. Ozempic and Mounjaro have different active ingredients and mechanisms. Using Ozempic to taper before switching could lead to over- or under-dosing.
Possibly. Clinical studies and patient reports suggest Mounjaro may lead to more significant weight loss than Ozempic due to its dual-action mechanism. However, results vary between patients.
Generally not. Doctors often begin treatment with the lowest dose of Mounjaro (2.5 mg) and slowly raise it to avoid side effects. Skipping titration may lead to severe side effects or poor tolerance.
Table of Contents
ToggleDisclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.